Corsair Capital Management L.P. Trims Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Corsair Capital Management L.P. decreased its holdings in IQVIA Holdings Inc. (NYSE:IQV) by 31.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 21,920 shares of the medical research company’s stock after selling 9,975 shares during the period. IQVIA comprises approximately 1.2% of Corsair Capital Management L.P.’s holdings, making the stock its 20th largest holding. Corsair Capital Management L.P.’s holdings in IQVIA were worth $5,194,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. CreativeOne Wealth LLC increased its stake in shares of IQVIA by 21.2% during the third quarter. CreativeOne Wealth LLC now owns 3,167 shares of the medical research company’s stock valued at $750,000 after buying an additional 553 shares during the period. Blueshift Asset Management LLC increased its stake in shares of IQVIA by 53.2% during the third quarter. Blueshift Asset Management LLC now owns 3,716 shares of the medical research company’s stock valued at $881,000 after buying an additional 1,290 shares during the period. Glenmede Trust Co. NA increased its stake in shares of IQVIA by 144.0% during the third quarter. Glenmede Trust Co. NA now owns 306,511 shares of the medical research company’s stock valued at $72,634,000 after buying an additional 180,890 shares during the period. Townsquare Capital LLC boosted its position in IQVIA by 5.8% during the third quarter. Townsquare Capital LLC now owns 12,214 shares of the medical research company’s stock valued at $2,894,000 after purchasing an additional 666 shares in the last quarter. Finally, Baldwin Investment Management LLC boosted its position in IQVIA by 8.6% during the third quarter. Baldwin Investment Management LLC now owns 3,548 shares of the medical research company’s stock valued at $841,000 after purchasing an additional 280 shares in the last quarter. Hedge funds and other institutional investors own 89.62% of the company’s stock.

IQVIA Stock Up 1.4 %

Shares of IQV stock opened at $203.99 on Wednesday. The stock has a 50 day moving average of $221.18 and a 200 day moving average of $226.75. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.76. The stock has a market cap of $37.02 billion, a P/E ratio of 26.41, a P/E/G ratio of 2.10 and a beta of 1.51. IQVIA Holdings Inc. has a twelve month low of $187.62 and a twelve month high of $261.73.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. TD Cowen dropped their price objective on IQVIA from $270.00 to $255.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. Argus raised IQVIA to a “strong-buy” rating in a research report on Wednesday, July 31st. Morgan Stanley dropped their price objective on IQVIA from $280.00 to $265.00 and set an “overweight” rating on the stock in a research report on Monday, November 4th. StockNews.com raised IQVIA from a “hold” rating to a “buy” rating in a research report on Wednesday, November 20th. Finally, JPMorgan Chase & Co. lowered their price target on IQVIA from $279.00 to $240.00 and set an “overweight” rating for the company in a report on Tuesday, November 5th. Four research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, IQVIA currently has a consensus rating of “Moderate Buy” and an average target price of $256.50.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.